Categories: Health

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

 | Source: BridgeBio Pharma, Inc.

PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that on April 9, 2025, the compensation committee of BridgeBio’s board of directors approved equity grants to 20 new employees in restricted stock units for an aggregate of 77,652 shares of the Company’s common stock. One-fourth of the shares underlying each employee’s restricted stock units will vest on May 16, 2026, with one-twelfth of the remaining shares underlying each such employee’s restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee’s continued employment with the Company or one of its subsidiaries on such vesting dates. All of the above-described awards were made under BridgeBio’s Amended and Restated 2019 Inducement Equity Plan (the “Plan”).

The above-described awards were each granted as an inducement material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted pursuant to the terms of the Plan. The Plan was adopted by BridgeBio’s board of directors in November 2019, and amended and restated on February 10, 2023 and on December 13, 2023.

About BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, Twitter and Facebook.

BridgeBio Contact:
Bubba Murarka, EVP Communications
contact@bridgebio.com
(650)-789-8220

GlobeNews Wire

Recent Posts

Best Free Spins No Deposit Casinos | Real Money Online Casino No Deposit – Wild Casino

New York City, NY, May 25, 2025 (GLOBE NEWSWIRE) -- Free spins at no deposit…

2 hours ago

Leading Proxy Advisory Firm Glass Lewis Recommends Radware Stockholders Vote in Favor of Compensation Proposal for Chief Executive Officer

TEL AVIV, Israel, May 25, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a global leader…

2 hours ago

MiningCoop: 2025s Top-Rated Bitcoin Cloud Mining Site Offering High-Yield Plans

Unlock the best free way to mine Bitcoin in 2025—no hardware, no upfront cost, just…

2 hours ago

PBK Miner Integrates AI for Better Yields

New York City,NY, May 23, 2025 (GLOBE NEWSWIRE) -- In a move set to transform…

2 hours ago

Zscaler Recognized as a Leader in the 2025 Gartner Magic Quadrant for Security Service Edge

Zscaler Positioned Highest On Ability to Execute in the Evaluation, Named a Leader for Fourth…

2 hours ago

GAC Launched Localization Initiative in Brazil, Debuts Five Core Models in the Brazilian Market.

SÃO PAULO, May 25, 2025 /PRNewswire/ -- On May 23, GAC held the Brazil Brand…

7 hours ago